Tag: AMyris

BestStevia and the Rest Stevia – SweeGen, Amyris and Cargill in the sweet spot

BestStevia and the Rest Stevia – SweeGen, Amyris and Cargill in the sweet spot

January 17, 2021 |

We all need some sweet stories these days but many are also starting the New Year by cutting sugar consumption with aims of losing weight or eating healthier, so here’s some sweet stevia news from the likes of Amyris and their No Compromise sweetener, SweeGen’s Bestevia launch, and Cargill’s EverSweet – all using Reb N, […]

Read More

Amyris links with Queer Eye alum for haircare brand

Amyris links with Queer Eye alum for haircare brand

January 11, 2021 |

In California, synthetic biology firm Amyris is launching a haircare brand with beauty influencer Jonathan Van Ness.  The partnership aims to “de-gender and revolutionize the haircare industry” by creating a line of hair health products employing Amyris’s hemi-squalane, a biobased and hydrating silicone alternative.  “I am more like the anti-transformation beauty expert: I want to […]

Read More

Hot50 companies lead in investments, moving forward in 2021 – iwi’s $10M investment, $73M valuation, Green Plains invests in Fluid Quip, Neste acquiring stake in Alterra Energy

Hot50 companies lead in investments, moving forward in 2021 – iwi’s $10M investment, $73M valuation, Green Plains invests in Fluid Quip, Neste acquiring stake in Alterra Energy

January 11, 2021 |

Looking for some good news? Well, look no further as hot off the press is good news from several Hot50 winners starting with plant-based omega-3 pioneers, Qualitas Health, DBA iwi, which has secured $10 million in venture funds at a $73 million post-money valuation, to accelerate growth and build their unique plant-based protein. And Fluid […]

Read More

Amyris receives Bonsucro Chain of Custody Certification

Amyris receives Bonsucro Chain of Custody Certification

December 28, 2020 |

In California, Amyris announced that it has received Bonsucro Chain of Custody Certification. The Bonsucro Chain of Custody Standard ensures that sustainability claims along the sugarcane supply chain are traceable from farmer to end user. Sustainability is a key pillar of Amyris’ No CompromiseTM commitment, and our leading synthetic biology platform delivers clean chemistry using […]

Read More

Amyris seals $50M deal with DSM Nutritional Products

Amyris seals $50M deal with DSM Nutritional Products

December 21, 2020 |

In California, Amyris announced the closing of a strategic transaction with DSM Nutritional Products Ltd., the first of three anticipated transactions management described during its recent virtual investor mini-series event, held on December 15, 2020. Under the terms of the agreement Amyris is licensing to DSM rights to assume the supply of Farnesene to Givaudan […]

Read More

Amyris reports record product revenue, on track for 4 new molecules at scale

Amyris reports record product revenue, on track for 4 new molecules at scale

November 7, 2020 |

In California, Amyris reports another strong quarter in 2020 with Product Revenue (Consumer & Ingredients) of $31 million was up 58% compared with the prior year quarter, with year-over-year revenue growth in Consumer (+203%) and Ingredients (+21%). Amyris is also on track to deliver four molecules at scale. Cash operating expense of $43 million improved […]

Read More

Amyris and Rosie Huntington-Whiteley Announce Creation Of New Clean Beauty Brand and Business Partnership

Amyris and Rosie Huntington-Whiteley Announce Creation Of New Clean Beauty Brand and Business Partnership

November 1, 2020 |

In California, Amyris and Rosie Huntington-Whiteley, model turned business woman and founder of beauty commerce destination, Rose Inc., announced the formation of a new company, Clean Beauty Collaborative, Inc. This new business venture will further expand Amyris’ presence in the clean beauty space beyond its Biossance skincare and Pipette baby and mother care brands. Clean […]

Read More

Amyris and IDRI enter license for RNA vaccine platform, beginning with COVID-19 vaccine

Amyris and IDRI enter license for RNA vaccine platform, beginning with COVID-19 vaccine

October 25, 2020 |

In California, Amyris, Inc. signed a Collaboration Agreement and License Agreement with the Infectious Disease Research Institute to advance a novel ribonucleic acid vaccine platform, including accelerating the development of a COVID-19 vaccine. The collaboration will combine IDRI’s RNA vaccine platform, including IDRI’s proprietary nanostructured lipid carrier platform, with Amyris’s semi-synthetic squalene. This has the […]

Read More

Arzeda and Amyris enter into joint development agreement for novel enzymes

Arzeda and Amyris enter into joint development agreement for novel enzymes

October 25, 2020 |

In Washington, Arzeda, the Protein Design Company, entered into a joint development agreement with Amyris to design and develop novel enzymes for Amyris with unique functionalities, which Amyris will incorporate into their fermentation process to facilitate production of the target high value ingredients. This marks the second joint project between the parties. Amyris and Arzeda […]

Read More

Navy and Amyris team on developing jet biofuel

Navy and Amyris team on developing jet biofuel

October 6, 2020 |

In California, biosynthetic research is being done in China Lake, California, by Naval Air Warfare Center Weapons Division and Amyris, Inc. Funded by the Defense Advanced Research Projects Agency’s Living Foundries: 1000 Molecules Program, NAWCWD and Amyris’ project starts with specially developed yeast cells and ends with a high-density missile fuel. Through the Living Foundries […]

Read More